Patients
Physicians
Sponsors
Oncologists
About Us
News
SPA
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
Spanish
Terms and Conditions
Privacy Policy
Change your consent
Spanish
Terms and Conditions
Privacy Policy
Change your consent
Spanish
Terms and Conditions
Privacy Policy
Change your consent
Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 16 days ago
Share
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
1000 patients around the world
Available in
Chile, United States, Mexico, Brazil
Hoffmann-La Roche
1000
Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
IMbrella B
Sponsor
Hoffmann-La Roche
Study type
Interventional
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT03768063
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Change your consent
English
Change your consent
English
Change your consent
Terms and Conditions
Privacy Policy
Terms and Conditions
Privacy Policy
Terms and Conditions
Privacy Policy
